Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 4:00 PM
Ignite Modification Date:
2025-12-26 @ 4:00 PM
NCT ID:
NCT04972006
Eligibility Criteria:
Inclusion Criteria:
* A clinical diagnosis of specific phobia- blood, injection-injury subtype
* Age between 8 and 16
* Spoken and reading fluency in English
* Third grade reading ability
* Parental availability to participate in treatment study sessions
* Parental spoken and reading fluency in English.
Exclusion Criteria:
* A comorbid, previously assigned diagnosis of attention deficit hyperactivity disorder (ADHD), major depressive disorder (MDD), generalized anxiety disorder (GAD) OR significant parental endorsement of inattentiveness, hyperactivity, prolonged depressed mood, or pervasive generalized worries that are interfering with the child's life at the phone screen level
* A diagnosed learning disorder in reading or information processing
* Parent-reported child unwillingness or lack of ability to participate in cognitive bias tasks (e.g., looking at needle or injection-related imagery, reading basic stories about needles or blood draws)
* Previous and/or concurrent participation in CBT-based, exposure therapy for the fear of injections.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
8 Years
Maximum Age:
16 Years
Study:
NCT04972006
Study Brief:
Protocol Section:
NCT04972006